Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
Ocugen reports FDA alignment on Phase 2/3 OCU410ST trial in Stargardt disease
Ocugen (OCGN) announced that alignment has been reached with the FDA to move forward with a Phase 2/3 pivotal confirmatory clinical trial for ...